2018. Intradermal immunotherapy with low-dose house dust mite allergens in patients with allergic rhinitis: A proof-of-concept study. Revista Alergia México. 65, 1 (Apr. 2018), 41–51. DOI:https://doi.org/10.29262/ram.v65i1.322.